氯霉素棕榈酸酯结构式
|
常用名 | 氯霉素棕榈酸酯 | 英文名 | Chloramphenicol palmitate |
---|---|---|---|---|
CAS号 | 530-43-8 | 分子量 | 561.538 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 691.6±55.0 °C at 760 mmHg | |
分子式 | C27H42Cl2N2O6 | 熔点 | 90ºC | |
MSDS | 中文版 美版 | 闪点 | 372.1±31.5 °C | |
符号 |
GHS08 |
信号词 | Warning |
氯霉素棕榈酸酯用途Chloramphenicol palmitate 是一种具有口服活性广谱抗生素 (antibiotic),对革兰氏阳性菌和革兰氏阴性菌有广泛的活性。Chloramphenicol palmitate 通过阻断肽基转移酶的合成来抑制细菌的蛋白质合成。Chloramphenicol palmitate 可作为含有氯霉素耐药基因的转化细胞的细菌筛选试剂 (bacterial selection agent)。 |
中文名 | 氯霉素棕榈酸酯 |
---|---|
英文名 | chloramphenicol palmitate |
中文别名 | (2R,3R)-2-[(2,2-二氯乙酰基)氨基]-3-羟基-3-(4-硝基苯基)丙基棕榈酸酯 | 棕榈酸氯霉素酯 |
英文别名 | 更多 |
描述 | Chloramphenicol palmitate 是一种具有口服活性广谱抗生素 (antibiotic),对革兰氏阳性菌和革兰氏阴性菌有广泛的活性。Chloramphenicol palmitate 通过阻断肽基转移酶的合成来抑制细菌的蛋白质合成。Chloramphenicol palmitate 可作为含有氯霉素耐药基因的转化细胞的细菌筛选试剂 (bacterial selection agent)。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 691.6±55.0 °C at 760 mmHg |
熔点 | 90ºC |
分子式 | C27H42Cl2N2O6 |
分子量 | 561.538 |
闪点 | 372.1±31.5 °C |
精确质量 | 560.242004 |
PSA | 121.45000 |
LogP | 9.04 |
外观性状 | 晶体,溶于水 |
蒸汽压 | 0.0±2.3 mmHg at 25°C |
折射率 | 1.526 |
储存条件 | 库房低温通风干燥 |
符号 |
GHS08 |
---|---|
信号词 | Warning |
危害声明 | H351 |
警示性声明 | P280 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn: Harmful; |
风险声明 (欧洲) | R40 |
安全声明 (欧洲) | 36/37-36-26 |
危险品运输编码 | NONH for all modes of transport |
RTECS号 | RT4735000 |
海关编码 | 29414000 |
海关编码 | 2924299090 |
---|---|
中文概述 | 2924299090. 其他环酰胺(包括环氨基甲酸酯)(包括其衍生物以及他们的盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 包装 |
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Structural, electronic, thermodynamical and charge transfer properties of Chloramphenicol Palmitate using vibrational spectroscopy and DFT calculations.
Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 101 , 335-42, (2013) The global problem of advancing bacterial resistance to newer drugs has led to renewed interest in the use of Chloramphenicol Palmitate (C27H42Cl2N2O6) [Palmitic acid alpha ester with D-threo-(-),2-di... |
|
Metabolism of some drugs by intestinal lactobacilli and their toxicological considerations.
Acta Pharmacol. Toxicol. (Copenh.) 58(1) , 11-5, (1986) The bacterial metabolism of three drugs (sulphasalazine, phthalylsulphathiazole and chloramphenicol palmitate) and two dyes (tartrazine and methyl red) has been studied using a resting culture techniq... |
|
The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis.
Pediatr. Res. 23(4) , 388-92, (1988) The effect of exocrine pancreatic function on the pharmacokinetics of the choramphenicol oral capsule (CAP-base), chloramphenicol palmitate oral liquid (CAP-P), and chloramphenicol succinate intraveno... |
Chlorambon |
detreopal |
CHLORAMPHENICOLPALMITATE,BP |
cap-palmitate |
Chloramphenicol palmitate |
Clorolifarina |
chloromycetinpalmitate |
Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester |
CHLORAMPHENICAL PALMITATE |
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate |
D-threo-(-)-2,2-Dichloro-N-(β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl)acetamide α-palmitate |
EINECS 208-477-9 |
MFCD00083597 |
CAP-P |
Chloramphenicol palmitate (ester) |
chloramphenicol 3'-palmitate |
(2R,3R)-2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl palmitate |
[R-(R*,R*)]-Hexadecanoic Acid 2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl Ester |
Chloropal |
D-threo-(-)-2,2-Dichloro-N-(b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl)acetamide a-Palmitate |
chlorophenicol palmitate |